{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:54:42Z","timestamp":1791060882777,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019385","name":"Kurume University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K14802"],"award-info":[{"award-number":["JP25K14802"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbadis.2026.168180","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:02:50Z","timestamp":1770235370000},"page":"168180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vesicular nucleotide transporter (VNUT)-dependent ATP secretion by hepatic stellate cells promotes liver fibrosis"],"prefix":"10.1016","volume":"1872","author":[{"given":"Masaharu","family":"Kabashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Hasuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiro","family":"Rikitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Niimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Tokubuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Gobaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Inoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168180_bb0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"10.1016\/j.bbadis.2026.168180_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2014 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168180_bb0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2026.168180_bb0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","article-title":"Liver fibrosis scores predict liver disease mortality in the United States population","volume":"66","author":"Unalp-Arida","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0025","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"ESSENCE study group, phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2026.168180_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168180_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051097","article-title":"Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured?","volume":"10","author":"Khanam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2026.168180_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1096\/fj.15-274563","article-title":"Purinergic signaling in scarring","volume":"30","author":"Ferrari","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2026.168180_bb0045","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1053\/j.gastro.2005.08.056","article-title":"Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States","volume":"129","author":"Ruhl","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.23279","article-title":"Increased caffeine consumption is associated with reduced hepatic fibrosis","volume":"51","author":"Modi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11302-017-9568-1","article-title":"Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling","volume":"13","author":"Moriyama","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbadis.2026.168180_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166013","article-title":"Vesicular ATP release from hepatocytes plays a role in the progression of nonalcoholic steatohepatitis","volume":"1867","author":"Tatsushima","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2026.168180_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tips.2017.10.007","article-title":"Clodronate: a vesicular ATP release blocker","volume":"39","author":"Moriyama","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2026.168180_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-83144-w","article-title":"Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury","volume":"11","author":"Hasuzawa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168180_bb0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.phrs.2016.11.040","article-title":"Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation","volume":"117","author":"Jiang","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2026.168180_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0188135","article-title":"The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin","volume":"12","author":"Feig","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2026.168180_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06689","article-title":"Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity","volume":"4","author":"Sakamoto","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168180_bb0090","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0095","doi-asserted-by":"crossref","first-page":"62780","DOI":"10.18632\/oncotarget.19376","article-title":"AMPK: a novel target for treating hepatic fibrosis","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2026.168180_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/liv.12110","article-title":"5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis","volume":"33","author":"Kim","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2026.168180_bb0105","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/nm.2490","article-title":"Stimulating healthy tissue regeneration by targeting the 5-HT 2B receptor in chronic liver disease","volume":"17","author":"Ebrahimkhani","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2026.168180_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11302-012-9304-9","article-title":"Vesicular and conductive mechanisms of nucleotide release","volume":"8","author":"Lazarowski","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bbadis.2026.168180_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183408","article-title":"Physiopathological roles of vesicular nucleotide transporter (VNUT), an essential component for vesicular ATP release","volume":"1862","author":"Hasuzawa","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbadis.2026.168180_bb0120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0002-9440(10)65501-0","article-title":"Synaptophysin: a novel marker for human and rat hepatic stellate cells","volume":"155","author":"Cassiman","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2026.168180_bb0125","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.bbamcr.2009.09.011","article-title":"TI-VAMP\/VAMP7 and VAMP3\/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy\/multivesicular body pathways","author":"Fader","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Res. 1793"},{"key":"10.1016\/j.bbadis.2026.168180_bb0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.intimp.2016.12.017","article-title":"Purinergic P2X7 receptor mediates acetaldehyde-induced hepatic stellate cells activation via PKC-dependent GSK3\u03b2 pathway","volume":"43","author":"Wu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2026.168180_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/ajpgi.00294.2003","article-title":"Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells","volume":"287","author":"Dranoff","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2026.168180_bb0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1152\/ajpcell.00371.2012","article-title":"Vesicular nucleotide transporter regulates the nucleotide content in airway epithelial mucin granules","volume":"304","author":"Sesma","year":"2013","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.bbadis.2026.168180_bb0145","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1002\/1873-3468.70166","article-title":"Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells","volume":"599","author":"Nomura","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2026.168180_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0155","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/hep.28526","article-title":"Platelets: no longer bystanders in liver disease","volume":"64","author":"Chauhan","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168180_bb0160","first-page":"1","article-title":"Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets","volume":"2","author":"Hiasa","year":"2014","journal-title":"Phys. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:20:48Z","timestamp":1791058848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0925443926000281"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168180","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vesicular nucleotide transporter (VNUT)-dependent ATP secretion by hepatic stellate cells promotes liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168180"}}